Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2010.11.26
关于设立香港子公司进展的公告
2010.11.13
关于控股子公司完成增资工商变更登记的公告
2010.10.23
第一届董事会第二十二次会议决议公告
2010.10.23
关于对成都深瑞畜产品有限公司增资的公告
2010.10.23
关于开展防止资金占用长效机制建立和落实情况的自查报告
2010.10.23
关于规范财务会计基础工作专项活动的自查和整改报告
2010.10.23
高级管理人员薪酬与绩效考核制度（2010年10月）
2010.09.14
第一届董事会第二十一次会议决议公告
2010.09.14
中国建银投资证券有限责任公司关于公司使用部分超额募集资金的保荐意见
2010.09.14
关于签署《募集资金三方监管协议之补充协议》的公告
第一页
上一页
150
151
152
153
154
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
